Selective histone deacetylase small molecule inhibitors: recent progress and perspectives-Reference-Cited by-同舟云学术

Selective histone deacetylase small molecule inhibitors: recent progress and perspectives

Published:2016-12-29 Issue:5 Volume:27 Page:621-636
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Qin Hai-Tao¹,Li Huan-Qiu²,Liu Feng¹

Affiliation:

1. Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and Department of Medicinal Chemistry, College of Pharmaceutical Sciences, Soochow University, Suzhou, PR China

2. Department of Medicinal Chemistry, College of Pharmaceutical Sciences, Soochow University, Suzhou, PR China

Funder

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2017.1276565

Reference94 articles.

1. Translating the Histone Code

2. Acetylation and deacetylation of non-histone proteins

3. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

4. Histone deacetylation in epigenetics: An attractive target for anticancer therapy

5. Histone Deacetylase Inhibitors: From Bench to Clinic

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid Affinity and Microsomal Stability Ranking of Crude Mixture Libraries of Histone Deacetylase Inhibitors;ACS Medicinal Chemistry Letters;2024-09-12

2. Discovery of novel pyrrolo[2,1-c][1,4]benzodiazepine-3,11-dione (PBD) derivatives as selective HDAC6 inhibitors for the efficient treatment of idiopathic pulmonary fibrosis (IPF) in vitro and in vivo;European Journal of Medicinal Chemistry;2024-09

3. Investigating Potential Cancer Therapeutics: Insight into Histone Deacetylases (HDACs) Inhibitions;Pharmaceuticals;2024-03-29

4. Multitargeting HDAC Inhibitors Containing a RAS/RAF Protein Interfering Unit;Journal of Medicinal Chemistry;2024-01-23

5. TMP269, a small molecule inhibitor of class IIa HDAC, suppresses RABV replication in vitro;Frontiers in Microbiology;2023-12-01